DETOXIFICATION TECHNIQUES FOR PERI-IMPLANTITIS
December 2019
CAN PATIENTS BE ALLERGIC TO TITANIUM DENTAL IMPLANTS?
October 2019
WHAT IS THE IDEAL MATERIAL TO FILL SCREW ACCESS
HOLES IN SCREW-RETAINED RESTORATIONS?
April 2019
“ POST-OPERATIVE PERIAPICAL PATHOLOGY AROUND DENTAL IMPLANTS” -a new article by Randolph Resnik, DMD, MDS
March 2019
“The Vulnerability of Dental Practices to Cyber Attacks?” -a new article by Gary Salman & Paul Murphy
January 2019
[vc_row us_bg_image=”3115″ us_bg_size=”contain” us_bg_repeat=”no-repeat” el_class=”masthead-newsletter” us_bg_image_source=”media”][vc_row el_class=”newsletter-row”] THE MISCH INSTITUTE NEWSLETTER [vc_row color_scheme=”alternate” el_class=”newsletter-content”][vc_column width=”1/3″ el_class=”orange-right”] UPCOMING EVENTS SURGICAL SESSIONS 1 – 5 Rosen Shingle Creek Resort Orlando , Florida [us_image image=”3430″ align=”center”] Session 1 Patient Evaluation, Treatment Planning, & Implant Placement into Abundant Bone February 8-9, 2019 Session 2 Treatment of the Edentulous Arch […]
August 2018
THE MISCH INSTITUTE NEWSLETTER IN MEMORIUM It is with heavy hearts today that we say farewell to one of our close Resnik Implant Institute family members, Dr. Michael D. Ginder of Athens, Ohio. He was a Misch graduate and a favorite of the faculty and staff. He not only was an excellent clinician, he was […]
July 2018
[vc_row us_bg_image=”3115″ us_bg_size=”contain” us_bg_repeat=”no-repeat” el_class=”masthead-newsletter” us_bg_image_source=”media”][vc_row el_class=”newsletter-row”] THE MISCH INSTITUTE NEWSLETTER [vc_row color_scheme=”alternate” el_class=”newsletter-content”][vc_column width=”1/2″ el_class=”orange-right”] New Prophylactic Antibiotic Protocol for Sinus Graft Procedures [us_image image=”3123″ align=”center”]For years, Augmentin (Amoxicillin-clavulanate) has been used as the first line antibiotic for the therapeutic and prophylactic treatment of sinus graft procedures because of its superior beta-lactamase coverage. With […]
June 2018
[vc_row us_bg_image=”3115″ us_bg_size=”contain” us_bg_repeat=”no-repeat” el_class=”masthead-newsletter” us_bg_image_source=”media”][vc_row el_class=”newsletter-row”] THE MISCH INSTITUTE NEWSLETTER [vc_row color_scheme=”alternate” el_class=”newsletter-content”][vc_column width=”1/2″ el_class=”orange-right”] Beware of the Complications of a New Drug Class: The “Biologics” A new class of therapeutic drugs are becoming more popular in the treatment of an array of medical conditions such as autoimmune disease and cancers. These new drugs […]